SG11202010236WA - The crystalline forms of a compound - Google Patents

The crystalline forms of a compound

Info

Publication number
SG11202010236WA
SG11202010236WA SG11202010236WA SG11202010236WA SG11202010236WA SG 11202010236W A SG11202010236W A SG 11202010236WA SG 11202010236W A SG11202010236W A SG 11202010236WA SG 11202010236W A SG11202010236W A SG 11202010236WA SG 11202010236W A SG11202010236W A SG 11202010236WA
Authority
SG
Singapore
Prior art keywords
compound
crystalline forms
crystalline
forms
Prior art date
Application number
SG11202010236WA
Inventor
Zhenping Wu
Wenji Li
Ling Feng
Original Assignee
Hutchison Medipharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hutchison Medipharma Ltd filed Critical Hutchison Medipharma Ltd
Publication of SG11202010236WA publication Critical patent/SG11202010236WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
SG11202010236WA 2018-04-20 2019-04-18 The crystalline forms of a compound SG11202010236WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810360892.4A CN110386937A (en) 2018-04-20 2018-04-20 The crystal form of compound and unformed
PCT/CN2019/083216 WO2019201298A1 (en) 2018-04-20 2019-04-18 The crystalline forms of a compound

Publications (1)

Publication Number Publication Date
SG11202010236WA true SG11202010236WA (en) 2020-11-27

Family

ID=68239951

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202010236WA SG11202010236WA (en) 2018-04-20 2019-04-18 The crystalline forms of a compound

Country Status (17)

Country Link
US (2) US11584750B2 (en)
EP (1) EP3781569A4 (en)
JP (2) JP2021522202A (en)
KR (1) KR20210005021A (en)
CN (2) CN110386937A (en)
AU (1) AU2019254995B2 (en)
BR (1) BR112020021394A2 (en)
CA (1) CA3097054A1 (en)
CL (1) CL2020002703A1 (en)
EA (1) EA202092120A1 (en)
IL (1) IL278054A (en)
MX (1) MX2020011070A (en)
PE (1) PE20211597A1 (en)
PH (1) PH12020551736A1 (en)
SG (1) SG11202010236WA (en)
TW (1) TW202012407A (en)
WO (1) WO2019201298A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110386937A (en) * 2018-04-20 2019-10-29 和记黄埔医药（上海）有限公司 The crystal form of compound and unformed

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014015523A1 (en) * 2012-07-27 2014-01-30 Hutchison Medipharma Limited Novel heteroaryl and heterocycle compounds, compositions and methods
CN105503877A (en) 2014-09-24 2016-04-20 和记黄埔医药（上海）有限公司 Imidazopyridazine compound and application thereof
CN110386937A (en) * 2018-04-20 2019-10-29 和记黄埔医药（上海）有限公司 The crystal form of compound and unformed

Also Published As

Publication number Publication date
WO2019201298A1 (en) 2019-10-24
JP2024040206A (en) 2024-03-25
AU2019254995A1 (en) 2020-11-12
MX2020011070A (en) 2020-11-06
CA3097054A1 (en) 2019-10-24
AU2019254995B2 (en) 2023-12-14
CL2020002703A1 (en) 2021-01-08
PE20211597A1 (en) 2021-08-18
BR112020021394A2 (en) 2021-01-26
PH12020551736A1 (en) 2021-06-07
KR20210005021A (en) 2021-01-13
JP2021522202A (en) 2021-08-30
US20210238180A1 (en) 2021-08-05
US11584750B2 (en) 2023-02-21
CN112074517A (en) 2020-12-11
EA202092120A1 (en) 2021-07-09
US20230151015A1 (en) 2023-05-18
EP3781569A4 (en) 2021-11-10
TW202012407A (en) 2020-04-01
IL278054A (en) 2020-11-30
EP3781569A1 (en) 2021-02-24
CN110386937A (en) 2019-10-29

Similar Documents

Publication Publication Date Title
GB201806578D0 (en) Novel compound
IL276644A (en) Novel crystalline forms
IL268852A (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
ZA202005431B (en) Herbicidal compounds
EP3619208C0 (en) Crystalline forms of a jak inhibitor compound
ZA202207543B (en) Pyridazinyl-thiazolecarboxamide compound
ZA202004148B (en) Herbicidal compounds
ZA202005531B (en) Herbicidal compounds
ZA202101671B (en) Imidazopyridinone compound
GB202011800D0 (en) Compound
IL278054A (en) The crystalline forms of a compound
GB201912411D0 (en) Crystalline forms of ivosidenib
GB201818028D0 (en) Crystalline materials
GB201816445D0 (en) Crystalline materials
FI3686191T3 (en) Crystalline sulfamide compound
IL272835A (en) The salts of a compound and the crystalline forms thereof
IL292206A (en) The salts of a compound and the crystalline forms thereof
IL276108A (en) Fasoracetam crystalline forms
GB201911797D0 (en) Crystalline forms
EP3630750A4 (en) The salts of a compound and the crystalline forms thereof
GB201915908D0 (en) Crystalline forms of entrectinib
GB201908466D0 (en) Compound
SG11202105355XA (en) Crystalline salts of corydalmine
GB201818349D0 (en) Herbicidal compounds
GB201818350D0 (en) Herbicidal compounds